Table 2.
Source | FAd | p-CA | 3-gluK | EA | Tiliroside | |||||
---|---|---|---|---|---|---|---|---|---|---|
β | p-Value | β | p-Value | β | p-Value | β | p-Value | β | p-Value | |
Model | 0.0026 | 0.0055 | 0.0018 | <0.0001 | 0.0001 | |||||
Lack of Fit | 0.3003 | 0.4017 | 0.2095 | 0.0876 | 0.0275 | |||||
β0 | 72.79 | 79.61 | 128.71 | 261.88 | 1776.29 | |||||
X1 | 2.23 | 0.0612 | 5.76 | 0.0140 | 23.60 | 0.0011 | 19.08 | 0.0084 | 340.85 | 0.0005 |
X2 | −7.29 | 0.0005 | −13.18 | 0.0004 | −35.20 | 0.0002 | −150.04 | <0.0001 | −791.46 | <0.0001 |
X3 | 0.97 | 0.3425 | 3.06 | 0.1067 | 4.50 | 0.2566 | 13.88 | 0.0281 | 42.31 | 0.3606 |
X1X2 | 0.80 | 0.5676 | 4.17 | 0.1164 | 3.87 | 0.4716 | −12.41 | 0.1110 | −189.56 | 0.0244 |
X1X3 | −2.51 | 0.1147 | −0.39 | 0.8648 | −1.18 | 0.8215 | −6.06 | 0.3880 | 1.47 | 0.9813 |
X2X3 | −1.38 | 0.3405 | 2.47 | 0.3123 | −0.50 | 0.9232 | −20.17 | 0.0256 | −4.49 | 0.9428 |
X12 | −6.13 | 0.0065 | −1.80 | 0.4680 | −0.45 | 0.9335 | 14.13 | 0.0880 | −111.48 | 0.1317 |
X22 | −11.24 | 0.0004 | −11.19 | 0.0045 | −34.38 | 0.0012 | −88.90 | <0.0001 | −666.39 | 0.0001 |
X32 | −5.07 | 0.0138 | −3.25 | 0.2145 | 0.26 | 0.9614 | 14.50 | 0.0819 | −91.28 | 0.2004 |
R2 | 0.9704 | 0.9598 | 0.9747 | 0.9963 | 0.9910 | |||||
Adjusted R2 | 0.9172 | 0.8874 | 0.9290 | 0.9895 | 0.9747 | |||||
Predicted R2 | 0.6131 | 0.5167 | 0.6450 | 0.9432 | 0.8576 |
FAd—ferulic acid derivative; pCA—p-coumaric acid; 3-gluK—kaempferol 3-glucoside; EA—ellagic acid; p < 0.0001 very highly significant, p < 0.01 very significant, p < 0.05 significant.